Regenerative Medical Solutions played a key role in the 5th Summit on Stem Cell-Derived Islets, held October 28-29, 2024, at Harvard University’s Joseph B. Martin Conference Center in Cambridge, MA. RMS proudly sponsored the prestigious event. Additionally, Dr. Jon S. Odorico, Scientific Founder of RMS and Professor of Transplant Surgery at the University of Wisconsin–Madison, served as a Conference Co-Chair alongside Dr. James Markmann, M.D., Ph.D., F.A.C.S., and Dr. Douglas Melton, Ph.D.
The summit, organized by the International Pancreas and Islet Transplant Association (IPITA), the Harvard Stem Cell Institute (HSCI), and Breakthrough T1D (formerly JDRF), brought together leading experts in diabetes research. During the event, important discussions were held on advancements in stem cell-derived islet biology. The event was particularly relevant to our work developing stem cell-derived islet-like clusters that can restore insulin production in diabetes patients. RMS is pioneering a patented regenerative cell therapy, developed through Dr. Odorico’s work, aimed at curing diabetes without the need for traditional immunosuppressive drugs, which can cause serious side effects.
At the summit, Dr. Odorico highlighted the significance of regenerative cell therapy in diabetes treatment. “We are working to develop a functional cure for diabetes that eliminates the need for lifelong immunosuppression,” he said. “The summit provided an invaluable opportunity for experts to collaborate and for emerging scientists to engage with the latest breakthroughs in diabetes stem cell treatments and bioengineering.”
Continuing the Momentum in Diabetes Research
With a commitment to revolutionizing diabetes treatment, RMS is actively seeking investors and partners to support its ongoing stem cell therapy research. We encourage anyone interested in supporting our work to get in touch about investing.
While the 5th Summit on Stem Cell-Derived Islets has concluded, its impact on the field will continue to shape advancements in stem cell-based diabetes therapies. More information about the event and its outcomes can be found at stemcellislet.ipita.org.